Delaware 2025-2026 Regular Session

Delaware House Bill HB56

Introduced
3/6/25  
Refer
3/6/25  
Engrossed
4/17/25  
Refer
4/17/25  

Caption

An Act To Amend Titles 18, 29, And 31 Of The Delaware Code Relating To Coverage For Removal Of Excess Skin And Subcutaneous Tissue.

Impact

If enacted, this bill would have significant implications for healthcare coverage in Delaware by broadening insurance protections for patients who require panniculectomies. Under the proposed legislation, all policies must provide coverage for these procedures if deemed medically necessary. This change is important not only for individual patients but also for the healthcare system overall, as it can help improve health outcomes and reduce long-term complications associated with untreated excess skin.

Summary

House Bill 56 is designed to amend the existing Delaware Code to provide insurance coverage for the removal of excess skin and subcutaneous tissue, specifically addressing the procedure known as panniculectomy. The bill mandates that both individual and group health insurance plans, including those provided by the state, must recognize and cover these medically necessary procedures. The focus on health consequences is notable, as excess skin can contribute to various health issues such as skin rashes, infections, and mobility challenges.

Sentiment

The sentiment towards HB 56 appears to be largely positive, especially among advocates for improved healthcare access. Proponents argue that providing coverage for the removal of excess skin addresses a vital health need that significantly impacts patients' quality of life. However, there may still be discussions regarding the implications of what constitutes 'medically necessary' within the provisions outlined in the bill.

Contention

One notable point of contention regarding the bill could involve defining the parameters of 'medical necessity.' While the bill targets specific health conditions stemming from excess skin, stakeholders may debate the criteria under which insurance companies must cover these procedures. This could potentially lead to opposing views on insurance costs and healthcare resource allocation, especially when enforcing coverage that varies significantly across different health insurance policies and plans.

Companion Bills

No companion bills found.

Previously Filed As

DE HB110

An Act To Amend Titles 18, 29, And 31 Of The Delaware Code Relating To Insurance Coverage For Termination Of Pregnancy.

DE HB362

An Act To Amend Title 18 Of The Delaware Code Relating To Coverage For Doula Services.

DE HB16

An Act To Amend Titles 29 And 31 Of The Delaware Code Relating To Ovarian Cancer.

DE HB54

An Act To Amend Title 18, Title 29, And Title 31 Of The Delaware Code Relating To Insurance Coverage Of Epinephrine Autoinjectors.

DE HB80

An Act To Amend Title 31 Of The Delaware Code Relating To Coverage Of Doula Services.

DE HB15

An Act To Amend Title 18 Of The Delaware Code Relating To Ovarian Cancer.

DE HB253

An Act To Amend Titles 16, 18, 29, And 31 Of The Delaware Code Relating To Mammograms.

DE SB272

An Act To Amend Titles 18 And 29 Of The Delaware Code Relating To Health Insurance, And Title 31 Of The Delaware Code Relating To Pharmacist Care.

DE HB150

An Act To Amend Title 31 Of The Delaware Code Relating To Medical Coverage For All Delaware Children.

DE SB232

An Act To Amend Title 18 Of The Delaware Code Relating To Insurance Coverage For Contraceptives.

Similar Bills

MD SB682

Maryland Medical Assistance Program - Gender-Affirming Treatment (Trans Health Equity Act of 2022)

MD HB746

Maryland Medical Assistance Program – Gender–Affirming Treatment (Trans Health Equity Act of 2022)

IL SB3105

EMPLOYEES-SUBCUTANEOUS IMPLANT

CA AB2467

Health care coverage for menopause.

OR SB1

Relating to the administration of epinephrine.

NJ A605

Permits emergency medical technicians to administer certain vaccines during certain declared public health emergencies.

NJ A941

Permits emergency medical technicians to administer certain vaccines during certain declared public health emergencies.

NV AB71

Revises the list of activities that constitute the practice of veterinary medicine to exclude the subcutaneous implantation of an identification microchip into an animal. (BDR 54-432)